Polity & Governance Prelims cum Mains

How hip implants went wrong

The news

  • An expert committee set up by the Health Ministry has indicted Johnson & Johnson for “suppressing” key facts on the harmful effects of the company’s “faulty” hip replacement systems, withdrawn globally after complications required many patients to undergo revision surgery.

How is hip replacement done?

  • The hip joint consists of a ball and a socket, which are covered with cartilage and surrounded by a lubricating membrane to protect against wear.
  • In total hip replacement, all components are replaced with prosthetic components (artificial devices that replaces a missing body part).
  • While a metal stem is placed into the hollow centre of the thighbone (femur), the prosthetic ball, socket and cartilage can be made of strong plastic, metal or ceramics.
  • The commonest hip implants are metal on polythene, and ceramic on polythene.

What kind are the implants at the centre of the current controversy?

  • These are metal on metal, with cobalt, chromium and molybdenum as major constituents.
  • Called ASR (Articular Surface Replacement) XL Acetabular System and ASR Hip Resurfacing System, these were being manufactured and sold for several years by Deputy International Limited (DePuy), UK, a subsidiary of Johnson & Johnson.

What problems arose with these?

  • When the prosthetic ball and socket rub against each other, it causes wear.
  • If the implant is metal on metal, this can sometimes releases metallic debris into the bloodstream.
  • This can lead to complications, sometimes requiring revision surgery.
  • Of the 93,000 patients implanted with ASR worldwide, many experienced serious adverse reactions, some requiring revision surgery to replace the ASR implant with another kind.
  • Because of this, the company recalled the product in 2010.

To what extent has it happened in India?

  • In India, the company got the licence to import the device in 2006.
  • By the time it was recalled worldwide, an estimated 4,700 ASR implants had been done in the country.
  • Amid concerns worldwide, the Health Ministry set up an expert committee headed by Dr Arun Kumar Agarwal in 2017 to examine issues arising out of faulty ASR implants in India.
  • The committee reviewed action taken by the company to replace faulty ASR implants, and reviewed compensation provided to those who had suffered.

What did the committee find?

  • The committee concluded that not only did patients undergo revision after first surgery, but in some cases, more than one revision surgeries have been performed.
  • Some of the patients had reported that they had to undergo excoriating pain.
  • Many patients reported general fatigue or local issues such as pseudo tumour, pain walking, metallosis (increase in Cobalt and Chromium levels, Asthenozoospermia (reduced sperm motility), cyst in kidney, claudication pain.
  • Besides physical problems, some of them informed that they are still having difficulty in carrying out their routine activities and are confined to bed which has led them to mental turmoil and agony.
  • The cost of revision surgery was reimbursed either by the company or the insurance firms.
  • The patients are still sceptical about their future with the implant in their body.

Recommendations of the committee:

  • The company should be made liable to pay at least Rs 20 lakh to each patient with such complications, and the reimbursement programme be extended until August 2025.
  • A central expert committee and a regional expert committee should be constituted by the Ministry for evaluation of patients’ claims in “respect of disability and suffering caused due to use of faulty ASR”.
  • The regional committee will determine whether there is permanent disability, and whether such disability has affected or will affect the patient’s earning capacity, and then submit its report to the central expert committee.
  • The central expert committee will determine the quantum of compensation.
  • It has recommended that the maximum amount be at par with the maximum granted for clinical trial-related death and permanent disability as per rules and guidelines of the Drug Controller General of India.
  • With 3,600 patients yet to traced, the firm has to give due diligence to trace those remaining patients who have received ASR but have not registered with the helpline.
  • Health assessment of patients should be reported once a year till 2025 and compliance report periodically, preferably six-monthly, submitted to the Ministry. Follow-up should be done regularly.
  • An independent registry should be established for tracking usage of high-risk medical devices.
  • Provisions for compensation should be included in Medical Device Rules if any serious adverse event or death is caused due to the sole use of a medical device.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: